NIAID announces funding ops for HIV Clinical Trial Networks, including TB and Hepatitis

By on .

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) and the leading funder of AIDS research, issued long-awaited funding announcements to create leadership groups for clinical research networks in HIV that will also address tuberculosis (TB) and hepatitis—leading co-morbidities in persons with HIV infection.

Requests for applications have been released for the following clinical research networks:

  • HIV and HIV-Associated Infections in Pediatric and Maternal Populations
  • Integrated Strategies to Prevent HIV Infection
  • Microbicides to Prevent HIV infection
  • Therapeutics for HIV/AIDS and HIV-Associated Infections in Adults
  • Vaccines to Prevent HIV infection

More information and links to the specific announcements can be found here:

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.